<DOC>
	<DOCNO>NCT02608645</DOCNO>
	<brief_summary>In study , within secondary prevention group patient ( diabetes mellitus , coronary artery disease , peripheral artery disease , event atherosclerotic cerebrovascular ) , statin use requirement , patient compliance reach target LDL-cholesterol level ( accord European guideline ) evaluate .</brief_summary>
	<brief_title>A Survey Under-treatment hypercholeSterolemia ( EPHESUS Trial )</brief_title>
	<detailed_description>In majority patient treat lipid lower agent control accordance lipid manual . In study , within secondary prevention group patient ( diabetes mellitus , coronary artery disease , peripheral artery disease , event atherosclerotic cerebrovascular ) , statin use requirement , patient compliance reach target LDL-cholesterol level ( accord European guideline ) evaluate . The investigator ' aim determine role education knowledge reach target LDL cholesterol level patient . İn addition , investigator want emphasize high-risk patient receive receive cholesterol-lowering treatment target value , ( LDL &lt; 100 mg / dL high -risk patient LDL &lt; 70 mg / dL high-risk patient ) determine rate patient importance reach target cholesterol level . İn addition , evaluate patient habit use statin dose .After screening , physician treatment decision reason document .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Patients coronary artery disease ( acute coronary syndrome , post myocardial infarction patient , history percutaneous coronary intervention , history coronary artery bypass graft ) Patients carotid artery lesion peripheral artery disease , Type 2 diabetes mellitus patient acute coronary syndrome last 1 month pregnancy first 6 month postpartum ICU patient emergency patient ... etc . ( polyclinic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>